Lonza supports development and manufacturing of ABL Bio’s bispecific antibody candidate with a complete and integrated end-to-end solution
Vikas Vij has been appointed as Chief Executive Officer (CEO) of the company
Abbas will closely partner with CBC's business teams to identify, assess, and pursue investment opportunities and strategic acquisitions
SCYNEXIS will receive an upfront payment of $90 million with future performance-based milestone payments and tiered royalties
EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging
ProBioGen was able to carry on its rapid growth trajectory by completing a significantly increased number of projects.
Essex enriches and complements Emmes’ services
He is Proficient in overseeing and leading teams for running successful business operations
Proposed combination enhances Pfizer’s position as a leading company in oncology
Subscribe To Our Newsletter & Stay Updated
